Glucose detection through surface-enhanced Raman spectroscopy: A review

Glucose detection is of vital importance to diabetes diagnosis and treatment. Optical approaches in glucose sensing have received much attention in recent years due to the relatively low cost, portable, and mini-invasive or non-invasive potentials. Surface enhanced Raman spectroscopy (SERS) endows the benefits of extremely high sensitivity because of enhanced signals and specificity due to the fingerprint of molecules of interest. However, the direct detection of glucose through SERS was challenging because of poor adsorption of glucose on bare metals and low cross section of glucose. In order to address these challenges, several approaches were proposed and utilized for glucose detection through SERS. This review article mainly focuses on the development of surface enhanced Raman scattering based glucose sensors in recent 10 years. The sensing mechanisms, rational design and sensing properties to glucose are reviewed. Two strategies are summarized as intrinsic sensing and extrinsic sensing. Four general categories for glucose sensing through SERS are discussed including SERS active platform, partition layer functionalized surface, boronic acid based sensors, and enzymatic reaction based biosensors. Finally, the challenges and outlook for SERS based glucose sensors are also presented.

Sensitive SERS glucose sensing in biological media using alkyne functionalized boronic acid on planar substrates

In this work, we propose a novel glucose binding mechanism on a highly sensitive SERS substrate, in order to overcome challenges in specific glucose detection in bio-fluids. We make use of phenylboronic acid as a receptor for saccharide capture onto the substrate and the ability of the captured glucose molecule to undergo secondary binding with an alkyne-functionalized boronic acid to form a glucose-alkyne-boronic acid complex. The formation of this complex shows high selectivity for glucose, over other saccharides. In addition, the alkyne group of the alkyne-functionalized boronic acid exhibits a distinct Raman peak at 1996 cm(-1) in a biological silent region (1800-2800 cm(-1)) where most endogenous molecules, including glucose, show no Raman scattering, thus offering a high sensitivity over other SERS glucose sensing. The substrate offers long-term stability, as well as high SERS enhancement to the glucose-alkyne boronic acid complex on substrate. In addition, the reversibility of SERS signals at various incubation stages also shows reusability capabilities, whereas positive results in clinical urine samples demonstrate clinical feasibility. All these strongly suggest that this newly developed SERS-based assay offers great potential in glucose sensing.

In vivo, transcutaneous glucose sensing using surface-enhanced spatially offset Raman spectroscopy: multiple rats, improved hypoglycemic accuracy, low incident power, and continuous monitoring for greater than 17 days

This paper presents the latest progress on quantitative, in vivo, transcutaneous glucose sensing using surface enhanced spatially offset Raman spectroscopy (SESORS). Silver film over nanosphere (AgFON) surfaces were functionalized with a mixed self-assembled monolayer (SAM) and implanted subcutaneously in Sprague-Dawley rats. The glucose concentration was monitored in the interstitial fluid of six separate rats. The results demonstrated excellent accuracy and consistency. Remarkably, the root-mean-square error of calibration (RMSEC) (3.6 mg/dL) and the root-mean-square error of prediction (RMSEP) (13.7 mg/dL) for low glucose concentration (<80 mg/dL) is lower than the current International Organization Standard (ISO/DIS 15197) requirements. Additionally, our sensor demonstrated functionality up 17 days after implantation, including 12 days under the laser safety level for human skin exposure with only one time calibration. Therefore, our SERS based sensor shows promise for the challenge of reliable continuous glucose sensing systems for optimal glycemic control.